"Parkinson's Disease"

A new study has found that Istradefylline, a drug already approved to treat Parkinson's disease, not only reduces the toxicity associated with the chemotherapy drug cisplatin, but also boosts its cancer-fighting power, promising a potential treatment to reduce the side effects of chemotherapy.

Psychotic symptoms are common in people with PD and are associated with poor prognosis, such as greater physical disability, cognitive and emotional impairment, caregiver distress, nursing home placement and death.